Plexium Is A Biotechnology Company Based In San Diegocaliforniafounded In 2018The Company Specializes In Developing Targeted Protein Degradationtpdtherapiesfocusing On Creating Precision Medicinesparticularly Monovalent Targeted Protein Degradersthese Therapies Aim To Selectively Degrade Drug Target Proteinsaddressing Challenges Posed By Existing Technologies Plexium S Pipeline Includes Treatments For Cancerneurodegenerationand Other Diseasesutilizing Innovative Approaches Like Molecular Gluesthe Company Has Made Significant Strides In Research And Developmentforming Strategic Partnerships With Academic Institutions And Biopharmaceutical Companies To Enhance Therapy Developmentled By Ceo Percival Barretto Koplexium Employs Around 95 People And Has Received Recognition For Its Contributions To The Field
No conferences found for this company.
| Company Name | Plexium Inc |
| Country |
United States
|
| Address | N/A |
| Telephone | N/A |
| N/A |
